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Leukocyte telomere length is 
associated with elevated plasma 
glucose and HbA1c in young 
healthy men independent of birth 
weight
L. G. Grunnet1,2, K. pilgaard3, A. Alibegovic4, C. B. Jensen5, L. Hjort1, S. E. ozanne6, 
M. Bennett7, A. Vaag1,8 & C. Brøns  1
telomeres are protein-bound regions of repetitive nucleotide sequences (ttAGGG) at the end of 
human chromosomes, and their length is a marker of cellular aging. Intrauterine growth restriction is 
associated with shorter blood cell telomeres at birth and individuals with type 2 diabetes have shorter 
telomeres. Individuals with a low birth weight (LBW) have an increased risk of metabolic disease and 
type 2 diabetes. Therefore, we aimed to investigate the relationship between birth weight and telomere 
length and the association between birth weight, telomere length and cardiometabolic phenotype 
in adulthood. Young, healthy men with LBW (n = 55) and normal birth weight (NBW) (n = 65) were 
examined including blood pressure, blood samples and body composition. Leukocyte telomere length 
was determined using a high-throughput qPCR method. The LBW men were more insulin resistant as 
determined by the HOMA-IR index. There was no difference in telomere length between LBW and NBW 
subjects. When adjusting for birth weight and cohort effect, significant negative associations between 
telomere length and fasting glucose (p = 0.003) and HbA1c (P = 0.0008) were found. In conclusion, no 
significant difference in telomere length was found between LBW and NBW men. The telomere length 
was negatively associated with glucose concentrations and HbA1c levels within the normal non-diabetic 
range independent of birth weight.
Telomeres are protein-bound regions of repetitive nucleotide sequences (TTAGGG) at the end of human chro-
mosomes. They maintain genomic stability by protecting the ends of the chromosome from deterioration1. DNA 
damage responses are activated when telomeres are shortened to a critical length, causing cellular senescence. 
Telomeres are longest at birth and shorten in most somatic cells postnatally due to both cell division and oxi-
dative stress2. In telomerase negative cells telomere shortening is irreversible and thus telomere length can be 
used as a biomarker for biological cellular aging3. In support of this, a number of studies have demonstrated that 
telomere shortening is affected by cell age4,5. Shorter telomeres have also been associated with a number of factors 
including male gender6, Caucasian race4, inflammation7, body composition and markers of glucose metabolism8. 
Results from a meta-analysis indicate that shortened leucocyte relative telomere length is significantly associated 
with type 2 diabetes and leucocyte telomere length with stroke and myocardial infarction9,10.
Early-life environmental exposures impact on risk of developing cardiometabolic disease later in life as sug-
gested by Hales and Barker11. It has been shown that fetal undernutrition resulting in a low birth weight (LBW) 
for gestational age, gives rise to a phenotype associated with increased risk of type 2 diabetes and cardiovascular 
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disease, and we and others have demonstrated multiple metabolic derangements in healthy young men born with 
LBW12–14. Similarly, offspring of women with gestational diabetes mellitus (GDM) thus exposed to fetal overnu-
trition, exhibit increased risk of type 2 diabetes in adulthood15. Our understanding of mechanisms underlying 
the association between fetal exposures and later risk of disease is not comprehensive. Several potential molecu-
lar mechanisms have been suggested, including accelerated cellular ageing, as it appears to play a role in disease 
progression. An adverse intrauterine environment may thus contribute to the formation of short telomeres giving 
rise to a senescent phenotype in the adulthood. Studies have shown that maternal stress and smoking during 
pregnancy is positively associated with shortened telomeres in the offspring16,17 and poor fetal growth has been 
shown to be associated with shorter telomeres in newborns18,19 as well as in adolescents20. However, a recent study 
found no increased acceleration of telomere shortening in adult women born small for gestational age21, and 
another study found no evidence of telomere abnormalities and oxidative DNA damage in adult offspring of type 
1 diabetes mothers as compared to control individual22.
The aim of the present study was to determine whether fetal malnutrition, as defined by a low birth weight, is 
associated with telomere shortening in a cohort of young healthy men, and to examine whether telomere length 
is associated with markers of cardiometabolic traits.
Results
Characteristics of the study participants. The participants born with a LBW had a median birth weight 
that was 1180 g lighter (P < 0.0001) than NBW individuals (2700 (2500–2800) vs. 3880 (3800–4000) g). As shown 
in Table 1, the LBW men had significantly shorter adult height (P < 0.0001), lower lean mass (P = 0.0008), ele-
vated fasting plasma glucose levels (P = 0.01) and evidence of insulin resistance (P = 0.04) as measured by the 
homeostatic model assessment of insulin resistance (HOMA-IR), predominantly reflecting insulin action in 
the liver, compared with NBW participants. Furthermore, there was a tendency towards higher waist-hip ratio 
(P = 0.06) and increased fasting insulin levels (P = 0.09) in the LBW men (Table 1). There were no other differ-
ences between the two groups.
telomere length and its association to phenotypic characteristics. There was no difference in leu-
kocyte telomere length between LBW and NBW participants (6.49 (6.24–6.88) vs 6.55 (6.23–6.99) kbp, P = 0.66) 
(Fig. 1).
In participants born with LBW, telomere length showed a positive association with systolic blood pressure 
(P = 0.05) and borderline significant positive association with diastolic blood pressure (P = 0.06) (Table 2). In 
addition, telomere length was negatively associated with fat% (P = 0.02), fasting plasma glucose (P = 0.002) and 
a tendency towards a negative association with HbA1c (P = 0.09) was observed. Among NBW participants, there 
LBW (n = 55) NBW (n = 65) P-value
Age (years) 23.3 (2.3) 23.0 (2.5) 0.48
Weight (kg) 76.6 (11.4) 79.1 (10.9) 0.21
Height (cm) 179.1 (57.2) 184.4 (68.0) <0.0001
BMI (kg/m2) 23.9 (3.5) 23.3 (3.1) 0.34
Waist-hip ratio 0.87 (0.05) 0.85 (0.07) 0.06
Lean mass (kg)# 56.5 (5.7) 60.7 (6.6) 0.0008
Fat mass trunk (kg)* 6.7 (4.8–11.3) 6.9 (5.3–9.6) 0.73
Fat mass total (kg) 16.3 (8.2) 15.6 (7.2) 0.60
Fat %# 18.7 (8.3) 16.8 (7.6) 0.25
SBP (mmHg) 128 (14) 127 (15) 0.89
DBP (mmHg) 69 (9) 70 (8) 0.52
F-p-glucose (mM) 5.5 (0.5) 5.3 (0.5) 0.01
F-p-insulin (pmol/l)* 33.7 (22.8–50.3) 27.1 (21.2–37.9) 0.09
HbA1c (%)* 5.2 (5.0–5.4) 5.1 (5.0–5.3) 0.30
HOMA-IR* 1.22 (0.85–1.78) 0.92 (0.72–1.33) 0.04
HOMA-B%* 49.7 (26.1–64.2) 47.2 (35.4–62.3) 0.72
FFA basal (µmol/l)* 363 (295–521) 340 (241–475) 0.18
Total cholesterol (mmol/l) 4.17 (1.03) 4.0 (0.82) 0.34
HDL (mmol/l) 1.22 (0.34) 1.28 (0.27) 0.31
LDL (mmol/l) 2.36 (0.73) 2.30 (0.74) 0.69
VLDL (mmol/l)* 0.40 (0.30–0.60) 0.40 (0.30–0.50) 0.63
Triglyceride (mmol/l)* 0.90 (0.70–1.26) 0.89 (0.69–1.10) 0.38
Leukocytes (10−9)* 5.5 (5.0–6.5) 5.4 (4.8–6.4) 0.60
Table 1. Characteristics of the study participants. Data are presented as mean (SD) and median (interquartile 
range) for normally and non-normally distributed variables, respectively, *Wilcoxon test, #n = 46 LBW and 52 
NBW.
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was a negative association between telomere length and HbA1c (P = 0.002) only. No associations to the blood 
lipid profile or obesity measurements were found in any of the birth weight groups.
In the combined group of LBW and NBW individuals, there were inverse associations between telomere 
length and fasting glucose and telomere length and HbA1c (Fig. 2). When adjusting for birth weight group and 
cohort effect, significant negative associations between telomere length and fasting glucose (β = −0.32, P = 0.003) 
and telomere length and HbA1c (β = −0.60, P = 0.0008) were found. In the combined group there was borderline 
significant negative association with fat% (β = −0.01, P = 0.06) and borderline positive association with systolic 
blood pressure (β = 0.006, P = 0.07).
Discussion
In the present study we showed that in young adulthood, there was no difference in leukocyte telomere length 
between individuals born with a LBW at term and age-matched individuals born with a normal birth weight. 
Interestingly, the telomere length was negatively associated with fasting plasma glucose levels and HbA1c when 
data from all the young healthy men was combined. Our current findings of elevated fasting glucose and insulin 
Figure 1. Estimated telomere length in LBW and NBW participants.
LBW (n = 55) NBW (n = 65)
β (95% CI) p-value β (95% CI) p-value
BMI (kg/m2) −0.03 (−0.07; 0.02) 0.20 −0.02 (−0.06; 0.03) 0.51
Waist-hip ratio 1.21 (−1,88; 4.30) 0.44 1.12 (−0.94; 3.18) 0.28
Lean mass (g)* −0.001 (−0.004; 0.02) 0.38 −0.001 (−0.004; 0.001) 0.26
Fat mass trunk (g)* −0.002 (−0.005; 0.002) 0.38 −0.002 (−0.005; 0.002) 0.35
Fat mass total (g)* −0.001 (−0.003; 0.001) 0.36 −0.009 (0.003; 0.001) 0.36
Fat % −0.02 (−0.04; −0.004) 0.02 −0.001 (−0.02; 0.02) 0.90
SBP (mmHg) 0.01 (0.00003; 0.02) 0.05 0.003 (−0.01; 0.01) 0.52
DBP (mmHg) 0.02 (−0.00007; 0.04) 0.06 0.002 (−0.02; 0.02) 0.78
F-p-glucose (mM) −0.55 (−0.90; −0.21) 0.002 −0.20 (−0.48; 0.08) 0.17
F-p-insulin (pmol/l) −0.001 (−0.006; 0.004) 0.64 −0.005 (−0.01; 0.003) 0.22
HbA1c (%) −0.45 (−0.96; 0.06) 0.09 −0.77 (−1.25; −0.29) 0.002
HOMA-IR −0.04 (−0.18; 0.09) 0.52 −0.14 (−0.34; 0.06) 0.16
HOMA-B% 0.0003 (−0.004; 0.004) 0.86 −0.0007 (−0.005; 0.004) 0.76
FFA basal µmol/l# 0.0003 (−0.001; 0.002) 0.66 0.0002 (−0.0008; 0.001) 0.71
Total cholesterol (mmol/l) 0.09 (−0.07; 0.35) 0.26 −0.09 (−0.26; 0.07) 0.27
HDL (mmol/l) 0.19 (−0.31; 0.68) 0.45 0.08 (−0.42; 0.58) 0.76
LDL (mmol/l) 0.06 (−0.17; 0.29) 0.59 −0.10 (−0.29; 0.08) 0.27
VLDL (mmol/l) −0.14 (−0.61; 0.33) 0.55 −0.30 (−1.18; 0.58) 0.50
Triglyceride (mmol/l) −0.06 (−0.23; 0.11) 0.49 −0.11 (−0.51; 0.29) 0.59
Table 2. Associations between telomere length and phenotypic characteristics. Estimated change in telomere 
length is presented as β (95% CI). *Change in telomere length per 100 g change in lean or fat mass, #n = 34 LBW 
and 37 NBW.
4Scientific RepoRts |          (2019) 9:7639  | https://doi.org/10.1038/s41598-019-43387-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
resistance among young men with LBW is in line with previous observations12,13 and underscore the importance 
of the intrauterine environment in the development of adult disease, including type 2 diabetes.
It is well-known that telomere attrition is associated with normal cellular aging23. More importantly, telomere 
attrition has been suggested to be a causal factor in the development of age-related diseases including type 2 dia-
betes9. Furthermore, studies have shown an impact of the intrauterine environment, as reflected by abnormal fetal 
growth, on telomere length in newborns19,24. In contrast, other studies have failed to show association between 
telomere length and birth weight, length or gestational age25 as well as to phenotype in adults aged from 16–51 
years exposed to an adverse fetal environment21,22,26. A recent study found no difference in telomere shortening 
during a five-year period between adult individuals born small for gestational age (SGA) and appropriate for 
gestational age (AGA)21. This is further supported by a larger study including 49–51 year-old males and females, 
where no associations between blood telomere length and birth weight was observed26. Likewise, another study 
showed that young adult offspring of mothers with pre-gestational type 1 diabetes did not differ in terms of tel-
omere length and DNA damage from BMI and weight-matched control individuals22. These studies are in support 
of our present findings of no difference in telomere length between two groups of young men distinguished by 
a large difference in birth weight. We cannot rule out that the telomere length of the current LBW subjects may 
have been shorter at birth and that time and lifestyle can have moderated and equalized this potential telomere 
difference. Nevertheless, based on previous and our findings of no persistent reduction of telomere length in adult 
LBW subjects, leucocyte telomere shortening is unlikely to play a central role in the association between fetal 
growth restriction and increased risk of developing type 2 diabetes later in life.
The rate of telomere attrition is highly variable27, and the telomere length can thus be modified by multiple 
factors from birth to adulthood. Shorter telomere has indeed been reported to be influenced by lifestyle factors 
including diet28, smoking16 and physical activity29. Besides environmental exposures, telomere lengths can be 
altered in response to social exposures as well. Interestingly, educational level26 and even parental responsive-
ness (describing parent and child interaction) seem to moderate the association between early adversity and 
telomere length, with higher parental responsiveness predicting longer telomeres30. In the current study we have 
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Figure 2. Associations between telomere length and fasting glucose (A) (n = 119) and HbA1c (B) (n = 115) in 
both LBW and NBW participants.
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no information on environmental factors which potentially could have affected the attrition of telomere length 
during childhood and adolescence.
Supporting our finding, several studies have showed an inverse correlation between telomere length and glu-
cose levels. Recently, Rosa et al. showed in patient newly diagnosed with type 2 diabetes, that relative telomere 
length was inversely associated with fasting plasma glucose levels and HbA1c levels after adjustment for age, 
sex and body mass index31. Ahmad et al. found an inverse association between leucocyte telomere length and 
2-h glucose concentrations in non-diabetic, middle-aged Caucasian adults32. The extent to which our findings 
of a negative association between leukocyte telomere length and fasting plasma glucose and HbA1c reflects a 
direct detrimental effect of early and minor changes in glucose metabolism on senescence at a cellular level, or 
whether this occurs as a result of confounding from associated anthropometric or lifestyle factors such as diet or 
physical activity is unknown. We have in a recent study showed that telomere length measured at the age of 9–16 
years in offspring of mothers GDM and control offspring was significantly associated with fasting insulin levels 
and HOMA-IR among the girls, whereas no association was observed among the boys20, indicating a potential 
different influence of gender on these associations. In the current study (which only included males), subjects 
with birth weights at the upper 10% range were excluded to minimize risk of confounding from the influence 
of gestational diabetes. In another cross-sectional study examining healthy individuals at 8–80 years of age, an 
inversely association between fasting glucose and telomere length was found. However, after backward selection, 
fasting glucose was no longer significantly associated with telomere length whereas adiposity measures includ-
ing both higher total and abdominal adiposity were significantly associated to shorter telomere length33. In the 
present study we found a tendency to an association between a higher fat percentage and shorter telomere length. 
Furthermore, telomere length at birth has been positively associated with lean mass and fat mass in newborns but 
only to lean mass at 12 months34, supporting that body composition plays a role in telomere shortening.
A meta-analysis showed an inverse association between leucocyte telomere length and risk of coronary heart 
disease35. In the present study, we found a significant positive association between telomere length and systolic 
blood pressure in LBW subjects, which was however, not significant in the pooled data set. This is supported 
by a study in adult females were no association between telomere length and blood pressure was found36 and 
further by a study were no association between telomere length and the risk of incident atrial fibrillation was 
observed37. Thus, more studies are needed to clarify the relationship between telomere length and cardiometa-
bolic risk factors.
The strength of the current study includes the homogeneity of the study population as all participants were 
recruited according to standardized criteria and studied prior to development of diseases. Age is known to affect 
telomere length, and the current study population was young, with an age ranging from 21–25 years, reducing 
potential bias. Knowing that shorter telomere is associated with male gender6 and Caucasian race, this study 
included only men of Caucasian ethnicity reducing the variability within the groups. The participants were born 
in and still residing in the Greater Copenhagen area ensuring demographic similarity. Since a family history of 
type 2 diabetes is a risk factor for developing the disease in itself, the exclusion criteria included diabetes in the 
family, in order to rule out the possibility of major genetic confounding. Also, obese subjects with a BMI greater 
than 30 kg/m2 and those with a self-reported high physical activity level were excluded to avoid studying meta-
bolic changes secondary to either obesity or a high level of physical activity.
The homogeneity of the study population is also a possible weakness since results are not necessarily general-
izable. Moreover, it could be that resourceful individuals are more likely to participate in time-consuming studies 
and may represent the healthiest part of the population.
In the present study a qPCR high throughput method was used allowing for a large sample size to be analyzed 
that would not have been feasible using other methods such as Southern blotting. Unfortunately, cord blood 
was not available in the present cohort to allow examination of white cell telomere shortening over time, and 
likewise data on lifestyle, social status and other factors known to influence telomere attrition over time was not 
available. The present study is a cross-sectional study and to rule out the long-term potential impact of shorter 
telomeres, longitudinal studies examine telomere shortening over time and its associations with metabolic and 
adiposity phenotypes are needed. Since leukocyte telomere length has been suggested as a proxy for muscle tel-
omere length32 and considering our findings of an association between telomere length and fasting glucose and 
HbA1c it would be highly interesting to examine telomere length in tissues involved in development of type 2 
diabetes such as muscle, adipose tissue and liver. It is indeed possible, that telomere length in other more meta-
bolically relevant tissues are not the same as in blood and furthermore, considering that some tissues are more 
vulnerable to oxidative stress than others, we might have seen an impact of the intrauterine environment on tel-
omere length in tissues such as muscle or pancreatic tissues, if they had been available. Finally, we cannot exclude 
the possibility that the lack of finding an association between telomere length and birth weight is due to a small 
sample size, though studies of similar number of adult participants are in support of our finding, as they have also 
reported a lack of association21,22,25,26. However, the current study may not be fully powered to detect differences 
in the subgroup analyses.
In conclusion, we found no difference in telomere length between young, healthy men born with a LBW 
compared to NBW individuals. In support of the existing literature, we found that telomere length is significantly 
negatively associated with fasting blood glucose level within the normal range. Since white blood cells are suitable 
for providing information on biomarkers, but probably not the best for providing insight into biology, further 
validation studies are needed that includes both blood and samples from metabolic active tissue.
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Research Design and Methods
participants. One hundred and twenty young, lean and healthy Caucasian males aged 21–25 years were 
included in a cross-sectional study. All individuals were singletons and born at term (weeks 39–41) in 1980–1983 
in Copenhagen County and were recruited from the Danish Medical Birth Registry according to birth weight and 
identical inclusion/exclusion criteria. Half of the subjects had a birth weight below the 10th percentile for gesta-
tional age (LBW) and the other half had a birth weight in the upper normal range (50–90th percentile) defined 
as normal birth weight (NBW). Participants with diabetes or with family members with known diabetes were 
excluded. Furthermore, a BMI ≥ 30 kg/m2, >10 hr exercise/week (self-reported) and an intake of medication 
known to affect glucose and lipid metabolism did also exclude individuals from participation.
Participants have been included in studies performed at Steno Diabetes Center, Gentofte, Denmark to deter-
mine the impact of the intrauterine environment and low birth weight on development of type 2 diabetes later in 
life, and have been extensively metabolically characterized according to separate protocols12,38–40. The association 
between LBW and cardiometabolic traits have been demonstrated and published previously12,38–40, however data 
are included in the current paper to describe the overall metabolic phenotype of the combined cohort and to 
associate it with telomere length.
To alleviate possible confounding of the results by factors such as alcohol, diet and physical activity, all par-
ticipants were subjected to identical standardization including criteria for diet and alcohol intake and amount of 
physical activity 3 days prior to the examination.
Protocols were approved by the regional ethics committee of the Capital Region of Denmark, and procedures 
were performed according to the principles of The Helsinki Declaration. All subjects have received thorough 
written and oral information before giving written informed consent.
experimental protocols. Detailed descriptions of the study procedures have previously been 
reported12,38–40. All 120 subjects underwent identical standardized blood testing after an overnight fast, anthropo-
metric and blood pressure measurements, a Dual-energy X-ray Absorptiometry (DXA) scan and determination 
of leukocyte telomere length. All blood samples were drawn from a polyethylene catheter placed in the antecubi-
tal vein and blood samples for plasma insulin were centrifuged immediately at 4 °C and stored at −80 °C prior to 
analysis. Plasma insulin, glucose, free fatty acids, leucocytes, HbA1c and serum concentrations of triglycerides, 
LDL and HDL cholesterols were analyzed by standard assays at Steno Diabetes Center, Gentofte, Denmark. Body 
composition was assessed by DXA (Lunar Radiation and Lunar Prodigy Advance, GE-healthcare, Madison, WI, 
USA). The homeostatic model assessment (HOMA) of insulin resistance (HOMA-IR) and beta cell function 
(HOMA-B%) were calculated according to Matthews et al.41. All methods were carried out in accordance with the 
relevant guidelines and regulations.
Leukocyte telomere length. Genomic DNA from blood was isolated and purified using QIAamp DNA 
Blood Midi and QIAamp DNA Tissue Mini kits from Qiagen Inc. (QIAGEN Inc. 27220 Turnberry Lane, Valencia, 
CA 91355). The DNA concentration and purity were measured by spectrophotometry.
Telomere length was determined using a validated quantitative polymerase chain reaction (qPCR) based anal-
ysis compared to the reference gene 36B4 as described previously42. In brief, the method included amplifying 
the telomeres of the experimental DNA against a single copy gene and comparing the ratio of telomere to single 
copy gene concentration to that of a reference DNA of known telomere length. Reference DNA was isolated from 
a culture of human vascular smooth muscle cells and its length determined by Southern blots. Both telomere 
primers and PCR master mixes were designed and prepared using Applied Biosystems reagents, as previously 
described42. Primer concentrations were: Tel.(1) 270 nM, Tel.(2) 900 nM, 36B4(1) 300 nM 36B4(2) 500 nM. The 
primer sequences 7 were (5′–3′): Tel.(1) GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGT, Tel.(2) 
TCCCGACTATCCCT-ATCCCTATCCCTATCCCTATCCCTA, 36B4(1) CAGCAAGTGGGAAGGTGTAATCC, 
36B4(2) CCCATTCTATCATCAACGGGTACAA. qPCR was performed in 0.1 ml tubes on a Rotor-Gene™ 6000 
QPCR thermocycler (Corbett Life Science, PO Box 435, Concorde, NSW 2137, Australia) with 15 μl of master 
mix and 5 μl of sample DNA per tube. Reference DNA was serially diluted 1:2, 6 times in water from 5 ng/μl to 
give a standard curve and 5 μl of each dilution was used per reaction. Sample DNA was diluted to 1 ng/μl and 
5 μl used per reaction. Standard curves generated from the reference DNA were used to derive absolute telomere 
length from all study participants. Analysis of both telomere length and 36B4 in experimental samples were 
run in triplicate and both telomere and 36B4 amplifications were performed on the same run. Average ratios of 
telomere to 36B4 concentration were calculated from the triplicates of each experimental sample and compared 
to the ratio for the reference DNA to derive telomere length43. Telomere length is expressed as absolute telomere 
length (kilo base pairs, kbp) as it allows for a more direct comparison of results between other experiments and 
different cell types.
statistical analyses. All analyses were performed using SAS 9.4 statistical software (SAS institute, Cary, 
NC, USA) and p ≤ 0.05 was considered statistically significant. Normally distributed data were described as mean 
(±standard deviation, (SD)) whereas median and interquartile range was used for skewed outcomes. Differences 
in anthropometric, metabolic and body composition outcomes between LBW and NBW subjects were ana-
lyzed using Student’s t-test for normally distributed data and Wilcoxon test for non-normally distributed data. 
Associations between telomere length as outcome variable and phenotypic characteristics as exposure variables 
were examined by linear regression models. After ensuring that the residuals were normally distributed, we cal-
culated β-coefficients and 95% confidence interval (CI). Since the study participants include subjects from 4 
different clinical studies, the regression models were adjusted for cohort effect when analyzed separately in LBW 
and NBW subjects (Table 2) and for cohort effect and birth weight group when analyzed together.
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Data Availability
Data generated in the present study are available from the corresponding author upon reasonable request.
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